Skip to main content
Equibles

Point72 Asset Management, L.P.

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 1603466 STAMFORD, CT
Back to ARQT Full portfolio

Position in ARQT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$9,503,412
-$4,417,650 QoQ
Shares Held
362,449
-38.7% QoQ
Ownership
0.288%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#51
of 271 holders
Holding Since
Sep 2020
18 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ARQT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. ARQT ranks #51 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ROIV
Roivant Sciences Ltd.
 4,473,478 $158,316,386
2 CYTK
Cytokinetics Inc
 1,587,712 $135,257,185
3 BBIO
BridgeBio Pharma, Inc.
 1,525,782 $113,640,243
4 AXSM
Axsome Therapeutics, Inc.
 416,516 $101,950,621
5 LEGN
Legend Biotech Corp
 3,076,124 $88,838,461
6 MDGL
Madrigal Pharmaceuticals, Inc.
 137,029 $73,577,721
7 CELC
Celcuity Inc.
 650,916 $68,098,831
8 ACAD
Acadia Pharmaceuticals Inc
 2,433,168 $61,559,150

All Filings in ARQT

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,503,412 362,449
2026-03-31 $13,921,062 590,877
2025-12-31 $12,346,414 425,152
2025-06-30 $20,825,658 1,485,425
2025-03-31 $12,988,675 830,478
2024-12-31 $24,426,561 1,753,522
2024-09-30 $2,272,789 244,386
2023-12-31 $1,034,569 320,300
2022-12-31 $16,332,924 1,103,576
2022-09-30 $72,336,643 3,785,277
2022-06-30 $42,352,154 1,987,431
2022-03-31 $32,700,571 1,697,849
2021-12-31 $54,840,230 2,644,177
2021-09-30 $47,591,436 1,992,107
2021-06-30 $24,462,756 896,400
2021-03-31 $12,708,949 439,300
2020-12-31 $24,619,376 875,200
2020-09-30 $1,267,400 43,256